NL8920901A - Werkwijze voor het behandelen en voorkomen van verlies van botmassa. - Google Patents

Werkwijze voor het behandelen en voorkomen van verlies van botmassa. Download PDF

Info

Publication number
NL8920901A
NL8920901A NL8920901A NL8920901A NL8920901A NL 8920901 A NL8920901 A NL 8920901A NL 8920901 A NL8920901 A NL 8920901A NL 8920901 A NL8920901 A NL 8920901A NL 8920901 A NL8920901 A NL 8920901A
Authority
NL
Netherlands
Prior art keywords
vitamin
bone
osteoporosis
compound
mammals
Prior art date
Application number
NL8920901A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Publication of NL8920901A publication Critical patent/NL8920901A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Disintegrating Or Milling (AREA)
  • Fertilizers (AREA)
  • Processing Of Solid Wastes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8920901A 1988-08-02 1989-08-02 Werkwijze voor het behandelen en voorkomen van verlies van botmassa. NL8920901A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22737188A 1988-08-02 1988-08-02
US22737188 1988-08-02

Publications (1)

Publication Number Publication Date
NL8920901A true NL8920901A (nl) 1990-07-02

Family

ID=22852835

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8920901A NL8920901A (nl) 1988-08-02 1989-08-02 Werkwijze voor het behandelen en voorkomen van verlies van botmassa.

Country Status (11)

Country Link
EP (1) EP0381750B1 (fr)
JP (1) JP3030854B2 (fr)
AT (1) ATE114471T1 (fr)
AU (1) AU634490B2 (fr)
CA (1) CA1341408C (fr)
DE (1) DE68919673T2 (fr)
GB (1) GB2231794B (fr)
MX (1) MX9203760A (fr)
NL (1) NL8920901A (fr)
SE (1) SE9001308D0 (fr)
WO (1) WO1990001321A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6096876A (en) * 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
JPWO2005077378A1 (ja) * 2004-02-18 2007-10-18 メルシャン株式会社 家畜哺乳動物の低カルシウム血症の予防、治療および／または処置方法
PT2148684E (pt) * 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
WO1984004527A1 (fr) * 1983-05-09 1984-11-22 Wisconsin Alumni Res Found PROCEDE DE PREPARATION DE LA VITAMINE D21alpha,25-DIHYDROXYLEE ET DES COMPOSES APPARENTES
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass

Also Published As

Publication number Publication date
SE9001308L (sv) 1990-04-10
EP0381750A1 (fr) 1990-08-16
GB2231794B (en) 1992-01-15
DE68919673T2 (de) 1995-06-01
WO1990001321A2 (fr) 1990-02-22
GB2231794A (en) 1990-11-28
AU634490B2 (en) 1993-02-25
ATE114471T1 (de) 1994-12-15
CA1341408C (fr) 2002-12-10
JP3030854B2 (ja) 2000-04-10
GB9006990D0 (en) 1990-08-29
SE9001308D0 (sv) 1990-04-10
AU4220389A (en) 1990-03-05
JPH03501388A (ja) 1991-03-28
EP0381750B1 (fr) 1994-11-30
WO1990001321A3 (fr) 1990-05-17
DE68919673D1 (de) 1995-01-12
MX9203760A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
US5403831A (en) Method of treating and preventing loss of bone mass using 1α-hydroxy-vitamin D2
CA2217260C (fr) Utilisation de derives de la vitamine d2 ou d4 pour fabriquer un medicament destine au traitement de l'hyperparathyroidisme secondaire
US5869473A (en) Method for treating and preventing hyperparathyroidism
Nowson et al. Vitamin D in Australia: issues and recommendations
US6376479B1 (en) Method for treating and preventing hyperparathyroidism
US20100087404A1 (en) Method of treating and preventing hyperparathyroidism with active vitamin d analogs
Chines et al. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature
Chan et al. Renal hypophosphatemic rickets
Okumura et al. Effect of 1α-hydroxyvitamin D3 on osteoporosis induced by immobilization combined with ovariectomy in rats
NL8920901A (nl) Werkwijze voor het behandelen en voorkomen van verlies van botmassa.
Gimenez et al. Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid
US6489361B1 (en) Phosphorus binder
Whitford Fluoride metabolism when added to salt
Deroisy et al. Effects of two 1-year calcium and vitamin D3 treatments on bone remodeling markers and femoral bone density in elderly women
Nortman et al. Renal osteodystrophy in end-stage renal failure
NZ203251A (en) Pharmaceutical compositions containing 1alpha,25,26-trihydroxycholecalciferol
Pierides et al. 1, 25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
US5942502A (en) Method of treating diseases resulting from calcium metabolism disorders
KR20000075514A (ko) 9,10-세코콜레스타-5,7,10(19)-트리엔-1,3-디올 또는 알파칼시돌
Caniggia et al. Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: a retrospective analysis
TABATA et al. Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1, 25 (OH) 2D3 treatment
Vitamin Vitamin D in Australia
De Broe et al. Calcium Balance in Renal Failure Patients with CKD 3~ 5 and in Dialysis Patients
WOMEN et al. EFFECTS OF TWO 1-YEAR CALCIUM AND VITAMIN D
Salmon Parathyroid Disturbances

Legal Events

Date Code Title Description
BV The patent application has lapsed